Why You’re Having Low Blood Sugar (And How to Prevent It)
I spoke with Gary Scheiner, CDCES, about why lows happen, how to treat them, and how to use your pump and CGM to reduce their frequency, duration, and severity.
$11 Insulin for All? Inside the Nonprofit Rewriting U.S. Drug Prices
Civica Rx is a nonprofit selling insulin for $11 a pen and $30 a vial, cutting out the middlemen and pricing games that have kept it unaffordable for decades.
Blue Circle Gives Free Support to Adults with Type 1 Diabetes - How it Works
Nw operating in 20 states and Washington, D.C., Blue Circle Health is expanding free, comprehensive support for adults living with type 1 diabetes across the country.
We break down the biggest tech stories from ATTD 2026 with endocrinologist Dr. David Ahn, exploring how fully closed loop systems, smarter sensing, and AI are reshaping the future of diabetes care.
Why Insulin Doesn’t Always Work the Same and How to Optimize It
I sat down with Gary Scheiner CDCES to discuss insulin variability, site failures, unexplained highs, and practical strategies to get insulin working efficiently.
An Islet Cell Transplant Without Immunosuppression Shows Promise - We Spoke with Patient #1
Encapsulated neonatal pig islet cells, implanted without immunosuppression in the OPF-310 trial, cut a type 1 diabetes patient’s insulin needs in half at six months, with further maturation expected.
This Implantable Artificial Pancreas Could Change Diabetes Care
Portal Diabetes is developing a fully closed-loop implantable pump that delivers insulin into the intraperitoneal cavity—achieving 4–5× faster insulin action.
As more insulin pumps move to pharmacy benefits, switching systems is easier than ever—but it’s also exposing serious gaps in safety, training, and support.
Here are the most listened to Diabetech podcast episodes of 2025, featuring expert interviews, diabetes tech and cure resear, and the future of diabetes technology.
How to Optimize Basal Insulin Settings for More Stable Glucose
I sat down with CDCES Gary Scheiner to discuss why basal insulin matters, how to know when it's off, and what stable basal looks like for insulin pumps and MDI.
How to Optimize CGM Alerts & Settings for the Best Results
I spoke with CDCES Gary Scheiner about how to take full advantage of continuous glucose monitor settings and alerts for the strongest diabetes management.
How Secure Is Your Insulin Pump? A Cybersecurity Expert Explains
A cybersecurity expert explains the precautions behind insulin pumps, CGMs, and why managing diabetes in secure government facilities requires a different level of protection.
We unpack how major companies are reimagining insulin delivery through tubeless designs, smarter algorithms, and the path to a fully automated insulin system.
We Spoke with Breakthrough T1D’s CEO About its Mission to Cure Type 1 Diabetes
We interviewed the CEO of Breakthrough T1D about how the organization reshaped diabetes tech over the years, and its latest endeavors aimed at speeding cell therapy research to cure type 1 diabetes.
